2019
DOI: 10.1016/j.atherosclerosis.2019.06.240
|View full text |Cite
|
Sign up to set email alerts
|

Alpha-Linolenic Acid Intake And The Risk Of Atherosclerotic Cardiovascular Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Thus, the competition for elongases and desaturases favors the synthesis of the n -6 series, i.e., mainly AA, which is metabolized into mainly pro-inflammatory and platelet activating derivatives. Therefore, the synthesis of the very-long-chain EPA and DHA are minimal, especially when the diet is relatively low in ALA [ 16 , 17 ]. Derivatives from EPA/DHA seem to be rather neutral with respect to inflammation and platelet activation, but contribute importantly to the resolution of inflammation by being so-called resolvins [ 13 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the competition for elongases and desaturases favors the synthesis of the n -6 series, i.e., mainly AA, which is metabolized into mainly pro-inflammatory and platelet activating derivatives. Therefore, the synthesis of the very-long-chain EPA and DHA are minimal, especially when the diet is relatively low in ALA [ 16 , 17 ]. Derivatives from EPA/DHA seem to be rather neutral with respect to inflammation and platelet activation, but contribute importantly to the resolution of inflammation by being so-called resolvins [ 13 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…As such, the potential cardiometabolic benefits of olive oil may in part be due to its predominant fatty acid composition of oleic acid and extends beyond the modulation of plasma lipids and lipoproteins alone (21) . Furthermore, the plant-based omega-3 (n-3) fatty acid α-linolenic acid, a precursor for the long-chain n-3 PUFA, has also been associated with improved cardiometabolic health outcomes in both observational studies and randomised controlled trials (22)(23)(24)(25)(26) as well as the attenuation of inflammatory mediators (27) . In a meta-analysis of randomised controlled trials, Amiri et al (28) showed that compared with other edible plant-based oils, canola oil (characterised by its high MUFA and α-linolenic acid composition) significantly improved cardiometabolic risk markers including TC, LDL-cholesterol, TC/HDL, LDL/HDL and apolipoprotein B.…”
mentioning
confidence: 99%